# OnCo record laura (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/laura/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "laura", "NCT03521154" ;
  schema:name "LAURA"@en ;
  schema:description "For stage III lung cancers with an EGFR mutation, a targeted pill after chemoradiation cut progression by more than 80%."@en ;
  schema:url <https://onco.cc/trials/laura/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03521154> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2018-07-19" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/>, <https://onco.cc/cancers/stage-iii-unresectable-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/osimertinib/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-lu-laura-osimertinib-stage-iii-nejm-2024/> .